Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Jan 31;13(1):210-212.
doi: 10.21037/tlcr-23-801. Epub 2024 Jan 22.

Biomarkers: a new frontier in lung cancer detection

Jehron Pura-Bryant #  1 , Justin A Olivera #  1 , Mara B Antonoff  2
Affiliations
Comment

Biomarkers: a new frontier in lung cancer detection

Jehron Pura-Bryant et al. Transl Lung Cancer Res. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-23-801/coif). The authors have no conflicts of interest to declare.

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Stephens EKH, Guayco Sigcha J, Lopez-Loo K, et al. Biomarkers of lung cancer for screening and in never-smokers-a narrative review. Transl Lung Cancer Res 2023;12:2129-45. 10.21037/tlcr-23-291 - DOI - PMC - PubMed
    1. Shen H, Jin Y, Zhao H, et al. Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer. BMC Med 2022;20:480 .10.1186/s12916-022-02681-x - DOI - PMC - PubMed
    1. Deboever N, Ostrin EJ, Antonoff MB. Liquid Biopsy as an Adjunct to Lung Screening Imaging. Thorac Surg Clin 2023;33:411-9. 10.1016/j.thorsurg.2023.04.004 - DOI - PubMed
    1. Raman V, Yong V, Erkmen CP, et al. Social Disparities in Lung Cancer Risk and Screening. Thorac Surg Clin 2022;32:23-31. 10.1016/j.thorsurg.2021.09.011 - DOI - PubMed
    1. Copeland J, Neal E, Phillips W, et al. Restructuring lung cancer care to accelerate diagnosis and treatment in patients vulnerable to healthcare disparities using an innovative care model. MethodsX 2023;11:102338 .10.1016/j.mex.2023.102338 - DOI - PMC - PubMed